| COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency AM Isidori, G Arnaldi, M Boscaro, A Falorni, C Giordano, R Giordano, ... Journal of endocrinological investigation 43, 1141-1147, 2020 | 136 | 2020 |
| Differential diagnosis of nonpalpable testicular lesions: qualitative and quantitative contrast-enhanced US of benign and malignant testicular tumors AM Isidori, C Pozza, D Gianfrilli, E Giannetta, A Lemma, R Pofi, ... Radiology 273 (2), 606-618, 2014 | 128 | 2014 |
| Is chronic inhibition of phosphodiesterase type 5 cardioprotective and safe? A meta-analysis of randomized controlled trials E Giannetta, T Feola, D Gianfrilli, R Pofi, V Dall’Armi, R Badagliacca, ... BMC medicine 12, 1-18, 2014 | 93 | 2014 |
| Cardiovascular features of possible autonomous cortisol secretion in patients with adrenal incidentalomas E Sbardella, M Minnetti, D D’Aluisio, L Rizza, MR Di Giorgio, F Vinci, ... European Journal of Endocrinology 178 (5), 501-511, 2018 | 68 | 2018 |
| Circadian rhythm of glucocorticoid administration entrains clock genes in immune cells: a DREAM trial ancillary study MA Venneri, V Hasenmajer, D Fiore, E Sbardella, R Pofi, C Graziadio, ... The Journal of Clinical Endocrinology & Metabolism 103 (8), 2998-3009, 2018 | 64 | 2018 |
| Targeting the NO‐cGMP‐PDE5 pathway in COVID‐19 infection. The DEDALO project AM Isidori, E Giannetta, R Pofi, MA Venneri, D Gianfrilli, F Campolo, ... Andrology 9 (1), 33-38, 2021 | 60 | 2021 |
| Clinical presentation, management and follow-up of 83 patients with Leydig cell tumors of the testis: a prospective case-cohort study C Pozza, R Pofi, M Tenuta, MG Tarsitano, E Sbardella, G Fattorini, ... Human reproduction 34 (8), 1389-1403, 2019 | 60 | 2019 |
| Chronic inhibition of PDE5 limits pro-inflammatory monocyte-macrophage polarization in streptozotocin-induced diabetic mice MA Venneri, E Giannetta, G Panio, R De Gaetano, D Gianfrilli, R Pofi, ... PloS one 10 (5), e0126580, 2015 | 59 | 2015 |
| The short Synacthen (corticotropin) test can be used to predict recovery of hypothalamo-pituitary-adrenal axis function R Pofi, C Feliciano, E Sbardella, N Argese, CP Woods, AB Grossman, ... The Journal of Clinical Endocrinology & Metabolism 103 (8), 3050-3059, 2018 | 55 | 2018 |
| Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection AM Isidori, R Pofi, V Hasenmajer, A Lenzi, R Pivonello The Lancet Diabetes & Endocrinology 8 (6), 472-473, 2020 | 54 | 2020 |
| A prospective study on contrast-enhanced magnetic resonance imaging of testicular lesions: distinctive features of Leydig cell tumours L Manganaro, V Vinci, C Pozza, M Saldari, D Gianfrilli, R Pofi, S Bernardo, ... European radiology 25, 3586-3595, 2015 | 54 | 2015 |
| PDE5 inhibition ameliorates visceral adiposity targeting the miR-22/SIRT1 pathway: evidence from the CECSID trial D Fiore, D Gianfrilli, E Giannetta, N Galea, G Panio, C di Dato, R Pofi, ... The Journal of Clinical Endocrinology & Metabolism 101 (4), 1525-1534, 2016 | 53 | 2016 |
| Erectile dysfunction and its management in patients with diabetes mellitus G Defeudis, D Gianfrilli, C Di Emidio, R Pofi, D Tuccinardi, A Palermo, ... Reviews in Endocrine and Metabolic Disorders 16, 213-231, 2015 | 50 | 2015 |
| Fixing the broken clock in adrenal disorders: focus on glucocorticoids and chronotherapy M Minnetti, V Hasenmajer, R Pofi, MA Venneri, KI Alexandraki, AM Isidori Journal of Endocrinology 246 (2), R13-R31, 2020 | 46 | 2020 |
| Diabetic nephropathy: focus on current and future therapeutic strategies R Pofi, F Di Mario, A Gigante, E Rosato, A M Isidori, A Amoroso, R Cianci, ... Current drug metabolism 17 (5), 497-502, 2016 | 42 | 2016 |
| Phosphodiesterase-5 inhibition preserves renal hemodynamics and function in mice with diabetic kidney disease by modulating miR-22 and BMP7 R Pofi, D Fiore, R De Gaetano, G Panio, D Gianfrilli, C Pozza, ... Scientific reports 7 (1), 44584, 2017 | 35 | 2017 |
| Plasma renin measurements are unrelated to mineralocorticoid replacement dose in patients with primary adrenal insufficiency R Pofi, A Prete, V Thornton-Jones, J Bryce, SR Ali, S Faisal Ahmed, ... The Journal of Clinical Endocrinology & Metabolism 105 (1), 314-326, 2020 | 34 | 2020 |
| Diabetic cardiomiopathy progression is triggered by miR122-5p and involves extracellular matrix: a 5-year prospective study R Pofi, E Giannetta, N Galea, M Francone, F Campolo, F Barbagallo, ... Cardiovascular Imaging 14 (6), 1130-1142, 2021 | 33 | 2021 |
| Everything you ever wanted to know about phosphodiesterase 5 inhibitors and the heart (but never dared ask): How do they work? R Pofi, D Gianfrilli, R Badagliacca, C Di Dato, MA Venneri, E Giannetta Journal of endocrinological investigation 39, 131-142, 2016 | 30 | 2016 |
| Recovery of the Hypothalamo-Pituitary-Adrenal Axis After Transsphenoidal Adenomectomy for Non–ACTH-Secreting Macroadenomas R Pofi, S Gunatilake, V Macgregor, B Shine, R Joseph, AB Grossman, ... The Journal of Clinical Endocrinology & Metabolism 104 (11), 5316-5324, 2019 | 29 | 2019 |
